Human cytomegalovirus: Latency and reactivation in the myeloid lineage

被引:176
作者
Sinclair, John [1 ]
机构
[1] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
human cytomegalovirus; latency; reactivation; dendritic cell; bone marrow progenitor; latency-associated transcripts;
D O I
10.1016/j.jcv.2007.11.014
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human cytomegalovirus (HCMV) persists as a sub-clinical, lifelong infection in the human host which is maintained at least in part by its carriage in the absence of detectable infectious virus: a hallmark of latent infection. In contrast, reactivation from latency in immuno-compromised individuals can result in serious disease. Understanding virus latency and reactivation, therefore, is essential for a full understanding of the biology and pathogenesis of this persistent human herpesvirus. However, the precise cellular sites in which HCMV is carried and the mechanisms regulating its latency and reactivation, during natural infection, remain poorly understood. Recent work, however, has led to a consensus opinion that cells of the myeloid lineage are one site of carriage of HCMV in vivo and that in myeloid dendritic cell (DC) progenitors the viral genome is carried latently in the absence of virus lytic gene expression. In contrast, differentiation of these cells to a mature DC phenotype is linked with reactivation of infectious virus resulting from differentiation-dependent chromatin remodelling of the viral major immediate-early promoter. Thus there is a crucial link between the differentiation of myeloid cells and transcriptional reactivation of latent virus which is likely to play a key role in viral pathogenesis. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:180 / 185
页数:6
相关论文
共 68 条
[1]  
ADLER SP, 1983, REV INFECT DIS, V5, P977
[2]   Reactivation of Epstein-Barr virus from latency [J].
Amon, W ;
Farrell, PJ .
REVIEWS IN MEDICAL VIROLOGY, 2005, 15 (03) :149-156
[3]   Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro [J].
Arthur, JL ;
Scarpini, CG ;
Connor, V ;
Lachmann, RH ;
Tolkovsky, AM ;
Efstathiou, S .
JOURNAL OF VIROLOGY, 2001, 75 (08) :3885-3895
[4]   Ets-2 Repressor Factor (ERF) mediates repression of the human cytomegalovirus major immediate-early promoter in undifferentiated non-permissive cells [J].
Bain, M ;
Mendelson, M ;
Sinclair, J .
JOURNAL OF GENERAL VIROLOGY, 2003, 84 :41-49
[5]   Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus [J].
Bego, M ;
Maciejewski, J ;
Khaiboullina, S ;
Pari, G ;
St Jeor, S .
JOURNAL OF VIROLOGY, 2005, 79 (17) :11022-11034
[6]   POLYMERASE CHAIN-REACTION FOR DETECTION OF HUMAN CYTOMEGALOVIRUS-INFECTION IN A BLOOD-DONOR POPULATION [J].
BEVAN, IS ;
DAW, RA ;
DAY, PJR ;
ALA, FA ;
WALKER, MR .
BRITISH JOURNAL OF HAEMATOLOGY, 1991, 78 (01) :94-99
[7]   FAILURE TO DETECT HUMAN CYTOMEGALOVIRUS DNA IN PERIPHERAL-BLOOD LEUKOCYTES OF HEALTHY BLOOD-DONORS BY THE POLYMERASE CHAIN-REACTION [J].
BITSCH, A ;
KIRCHNER, H ;
DUPKE, R ;
BEIN, G .
TRANSFUSION, 1992, 32 (07) :612-617
[8]   Peripheral blood CD14+ cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome [J].
Bolovan-Fritts, CA ;
Mocarski, ES ;
Wiedeman, JA .
BLOOD, 1999, 93 (01) :394-398
[9]   Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells [J].
Cheung, Allen K. L. ;
Abendroth, Allison ;
Cunningham, Anthony L. ;
Slobedman, Barry .
BLOOD, 2006, 108 (12) :3691-3699
[10]  
DEGRAANHENTZEN YCE, 1989, TRANSFUSION, V29, P757